• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗丙型肝炎相关肝病。

Cure of HCV related liver disease.

机构信息

Liver Institute of Virginia, Bon Secours Health System, Richmond and Newport News, Virginia, USA.

出版信息

Liver Int. 2015 Jan;35 Suppl 1:71-7. doi: 10.1111/liv.12734.

DOI:10.1111/liv.12734
PMID:25529090
Abstract

Chronic hepatitis C virus (HCV) causes chronic liver injury and can lead to cirrhosis and hepatocellular carcinoma (HCC). HCV can also interact with the immune system to cause several HCV related disorders including essential mixed cryoglobulinemia, vasculitis, dermatitis, glomerulonephritis and lymphoma. A strong association between HCV and diabetes mellitus also exists. These extrahepatic features may lead to increased fatigue and a reduced quality of life. It is now possible to cure most patients with chronic HCV using oral antiviral therapy. Many of these HCV-related disorders and symptoms can be cured when HCV is eradicated. However, some patients may have irreversible injury to extrahepatic sites, cirrhosis that cannot resolve, an increased risk for HCC, persistent fatigue and a reduced quality of life, despite achieving sustained virological response.

摘要

慢性丙型肝炎病毒(HCV)可引起慢性肝损伤,并可导致肝硬化和肝细胞癌(HCC)。HCV 还可以与免疫系统相互作用,导致几种与 HCV 相关的疾病,包括原发性混合性冷球蛋白血症、血管炎、皮炎、肾小球肾炎和淋巴瘤。HCV 与糖尿病之间也存在很强的关联。这些肝外特征可能导致疲劳加重和生活质量降低。目前,使用口服抗病毒治疗可以治愈大多数慢性 HCV 患者。当 HCV 被根除时,许多与 HCV 相关的疾病和症状都可以治愈。然而,尽管实现了持续病毒学应答,一些患者可能仍有肝外部位的不可逆转损伤、无法消退的肝硬化、HCC 的风险增加、持续疲劳和生活质量降低。

相似文献

1
Cure of HCV related liver disease.治疗丙型肝炎相关肝病。
Liver Int. 2015 Jan;35 Suppl 1:71-7. doi: 10.1111/liv.12734.
2
Manifestations of chronic hepatitis C virus infection beyond the liver.慢性丙型肝炎病毒感染的肝脏外表现。
Clin Gastroenterol Hepatol. 2010 Dec;8(12):1017-29. doi: 10.1016/j.cgh.2010.08.026. Epub 2010 Sep 24.
3
Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: A case series.尽管使用包括直接作用抗病毒药物索磷布韦在内的新型口服抗病毒疗法治愈了丙型肝炎,但混合性冷球蛋白血症仍持续存在:病例系列报道
Postgrad Med. 2015 May;127(4):413-7. doi: 10.1080/00325481.2015.1021660. Epub 2015 Mar 7.
4
Extrahepatic manifestations in chronic hepatitis C virus carriers.慢性丙型肝炎病毒携带者的肝外表现。
Lupus. 2015 Apr;24(4-5):469-82. doi: 10.1177/0961203314556140.
5
Current status of hepatitis C virus infection in Korea.韩国丙型肝炎病毒感染的现状。
Intervirology. 2006;49(1-2):70-5. doi: 10.1159/000087266.
6
Antiviral therapy: why does it fail in HCV-related chronic hepatitis?抗病毒治疗:为什么它在 HCV 相关慢性肝炎中失败?
Expert Rev Anti Infect Ther. 2011 May;9(5):535-43. doi: 10.1586/eri.11.10.
7
Achieving sustained virological response: what's the impact on further hepatitis C virus-related disease?实现持续病毒学应答:对进一步的丙型肝炎病毒相关疾病有何影响?
Expert Rev Gastroenterol Hepatol. 2015 May;9(5):559-66. doi: 10.1586/17474124.2015.1001366. Epub 2015 Jan 12.
8
Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders.遗传性出血性疾病患者中丙型肝炎感染的长期随访。
J Hepatol. 2014 Jan;60(1):39-45. doi: 10.1016/j.jhep.2013.08.010. Epub 2013 Aug 23.
9
Hepatitis C: Does Successful Treatment Alter the Natural History and Quality of Life?丙型肝炎:成功治疗是否改变其自然史和生活质量?
Gastroenterol Clin North Am. 2020 Jun;49(2):301-314. doi: 10.1016/j.gtc.2020.01.007. Epub 2020 Mar 29.
10
Does antiviral therapy prevent hepatocellular carcinoma?抗病毒治疗能预防肝细胞癌吗?
Antivir Ther. 2011;16(6):787-95. doi: 10.3851/IMP1895.

引用本文的文献

1
Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial.扶正化瘀植物药配方治疗慢性丙型肝炎患者肝纤维化的疗效和安全性:一项2期临床试验结果
Evid Based Complement Alternat Med. 2022 Jul 15;2022:4494099. doi: 10.1155/2022/4494099. eCollection 2022.
2
Autoantibodies and Rheumatologic Manifestations in Hepatitis C Virus Infection.丙型肝炎病毒感染中的自身抗体与风湿性表现
Biology (Basel). 2021 Oct 20;10(11):1071. doi: 10.3390/biology10111071.
3
Eradication of hepatitis C virus with direct-acting antivirals improves glycemic control in diabetes: A multicenter study.
直接作用抗病毒药物根除丙型肝炎病毒可改善糖尿病患者的血糖控制:一项多中心研究。
JGH Open. 2020 Dec 19;5(2):228-234. doi: 10.1002/jgh3.12474. eCollection 2021 Feb.
4
Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.分析丙型肝炎后肝硬化患者的血浆 tenascin-C:一项前瞻性研究。
Dig Dis Sci. 2018 Mar;63(3):653-664. doi: 10.1007/s10620-017-4860-z. Epub 2018 Jan 12.
5
A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases.糖尿病管理的不同视角:控制病毒性肝病
J Diabetes Res. 2017;2017:5625371. doi: 10.1155/2017/5625371. Epub 2017 Mar 2.
6
Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.丙型肝炎病毒清除与人类免疫缺陷病毒/丙型肝炎病毒合并感染中与肝脏无关的非获得性免疫缺陷综合征相关事件
Hepatology. 2017 Aug;66(2):344-356. doi: 10.1002/hep.29071. Epub 2017 Jun 22.
7
Expression of NS3/NS4A Proteins of Hepatitis C Virus in Huh7 Cells Following Engineering Its Eukaryotic Expression Vector.构建丙型肝炎病毒NS3/NS4A蛋白真核表达载体后在Huh7细胞中的表达
Jundishapur J Microbiol. 2015 Nov 26;8(11):e27355. doi: 10.5812/jjm.27355. eCollection 2015 Nov.
8
Living with Fibrosis: From Diagnosis to Future Hope.与纤维化共存:从诊断到未来希望
Front Pharmacol. 2015 Dec 16;6:288. doi: 10.3389/fphar.2015.00288. eCollection 2015.